CORDIS · 101103076 · HORIZON

MARC SE-Africa Mitigating Antimalarial Resistance Consortium in South-East Africa

Coordinator: UNIVERSITY OF CAPE TOWN (ZA)

BACKGROUND: Gains achieved in reducing the burden of malaria and advancing its elimination are now threatened by the independent emergence and local spread of artemisinin-resistant parasites in East Africa. Protecting the efficacy of the current first-line malaria treatments, all of which are artemisinin-based, is now a top public health priority. OBJECTIVE: The Mitigating Antimalarial Resistance Consortium for South-East Africa (MARC SE-Africa) is designed to promote the translation of evidence of artemisinin and partner drug resistance of public health significance into policy and practice.…

EU contribution
Total cost
Period
2023-04-01 → 2027-03-31
Framework
Horizon Europe (2021–2027)
Funding scheme
HORIZON-JU-RIA
Call
HORIZON-JU-GH-EDCTP3-2022-01
Status
SIGNED

About Horizon Europe (2021–2027)

Horizon Europe is the EU's current research and innovation programme, covering 2021 to 2027 with a budget of roughly €95.5 billion. Its three pillars are Excellent Science (frontier research and mobility), Global Challenges and European Industrial Competitiveness (mission-driven collaborative projects in health, climate, digital, security and food) and Innovative Europe (the EIC and EIT). It also funds five EU Missions targeting cancer, climate adaptation, smart cities, oceans and soils.

The project runs over approximately 4 years from 2023-04-01 to 2027-03-31.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon Europe (2021–2027) programme, under the HORIZON-JU-RIA funding scheme.
Which EU programme funds it?
The project is funded under Horizon Europe (2021–2027), call HORIZON-JU-GH-EDCTP3-2022-01.
Who coordinates the project?
The project is coordinated by UNIVERSITY OF CAPE TOWN (ZA).
What is the project timeline?
The project runs from 2023-04-01 to 2027-03-31 — approximately 4 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 101103076.